首页 > 最新文献

Farmaco (Societa chimica italiana : 1989)最新文献

英文 中文
Synthesis and biological activity of M6-P and M6-P analogs on fibroblast and keratinocyte proliferation M6-P及其类似物的合成及其对成纤维细胞和角化细胞增殖的生物活性
Pub Date : 2005-09-01 DOI: 10.1016/j.farmac.2005.06.006
Caroline Clavel , Véronique Barragan-Montero , Xavier Garric , Jean-Pierre Molès , Jean-Louis Montero

A new synthetic route to obtain the carboxylate analog of mannose 6-phosphate (M6-P) is presented. The effects of the M6-P, the carboxylate and two other analogs (the phosphonate and the α,β ethylenic carboxylate) on the proliferation of human keratinocytes and dermal fibroblasts as well as on the proliferation of a murine fibroblast cell line, 3T3-J2 are tested. We observed that M6-P is a potent inhibitor of proliferation of both fibroblasts and keratinocytes. Among its analogs, the phosphonate showed a similar effect on human dermal fibroblasts but not on keratinocytes.

提出了一种合成甘露糖6-磷酸羧酸类似物(M6-P)的新方法。研究了M6-P、羧酸盐和另外两种类似物(膦酸盐和α,β乙烯羧酸盐)对人角质形成细胞和真皮成纤维细胞增殖的影响,以及对小鼠成纤维细胞系3T3-J2的增殖的影响。我们观察到M6-P是一种有效的成纤维细胞和角化细胞增殖抑制剂。在其类似物中,膦酸盐对人皮肤成纤维细胞有类似的作用,但对角质形成细胞没有作用。
{"title":"Synthesis and biological activity of M6-P and M6-P analogs on fibroblast and keratinocyte proliferation","authors":"Caroline Clavel ,&nbsp;Véronique Barragan-Montero ,&nbsp;Xavier Garric ,&nbsp;Jean-Pierre Molès ,&nbsp;Jean-Louis Montero","doi":"10.1016/j.farmac.2005.06.006","DOIUrl":"10.1016/j.farmac.2005.06.006","url":null,"abstract":"<div><p>A new synthetic route to obtain the carboxylate<span> analog of mannose 6-phosphate (M6-P) is presented. The effects of the M6-P, the carboxylate and two other analogs (the phosphonate and the α,β ethylenic carboxylate) on the proliferation of human keratinocytes and dermal fibroblasts as well as on the proliferation of a murine fibroblast cell line, 3T3-J2 are tested. We observed that M6-P is a potent inhibitor of proliferation of both fibroblasts and keratinocytes. Among its analogs, the phosphonate showed a similar effect on human dermal fibroblasts but not on keratinocytes.</span></p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 9","pages":"Pages 721-725"},"PeriodicalIF":0.0,"publicationDate":"2005-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.06.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25194602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
PEG-metronidazole conjugates: synthesis, in vitro and in vivo properties 聚乙二醇甲硝唑缀合物:合成、体外和体内性质
Pub Date : 2005-09-01 DOI: 10.1016/j.farmac.2005.04.015
Cinzia Bersani, Manuela Berna, Gianfranco Pasut, Francesco Maria Veronese

Metronidazole (MTZ), a drug used for the treatment of protozoal infections caused by protozoa and anaerobic microorganisms, was conjugated to linear or branched poly(ethylene glycol) of 5,000, 10,000 and 20,000 Da. An ester linkage between polymer and drug was used in the coupling to yield a polymeric prodrug. The modification allowed overcoming the known MTZ solubility problem leading us to obtain a bioconjugate more suitable for parental administration. The conjugates of various molecular weight polymers have been tested in vitro toward chemical degradation and digestive enzymes. It was found that molecular weight and shape of PEG is critical for the prodrugs stability. Good resistance in the stomach acidic media was found and a slow release of the drug in the large intestinal fluid may take place. In vivo studies carried out following i.v. or s.c. administration to mice revealed improved pharmacokinetics properties upon conjugation.

甲硝唑(MTZ)是一种用于治疗由原生动物和厌氧微生物引起的原生动物感染的药物,它与5000、10000和20000 Da的线性或支链聚乙二醇偶联。聚合物和药物之间的酯键在偶联中产生聚合物前药。该修饰允许克服已知的MTZ溶解度问题,从而使我们获得更适合亲代给药的生物偶联物。不同分子量聚合物的缀合物在体外对化学降解和消化酶进行了测试。结果表明,聚乙二醇的分子量和形状对前体药物的稳定性至关重要。在胃酸介质中发现了良好的耐药性,并且可以在大肠液中缓慢释放药物。在小鼠体内进行的静脉注射或s.c.c给药研究表明,结合后的药代动力学特性得到改善。
{"title":"PEG-metronidazole conjugates: synthesis, in vitro and in vivo properties","authors":"Cinzia Bersani,&nbsp;Manuela Berna,&nbsp;Gianfranco Pasut,&nbsp;Francesco Maria Veronese","doi":"10.1016/j.farmac.2005.04.015","DOIUrl":"10.1016/j.farmac.2005.04.015","url":null,"abstract":"<div><p><span><span>Metronidazole (MTZ), a drug used for the treatment of </span>protozoal infections caused by protozoa and </span>anaerobic microorganisms<span>, was conjugated to linear or branched poly(ethylene glycol) of 5,000, 10,000 and 20,000 Da. An ester linkage between polymer and drug was used in the coupling to yield a polymeric prodrug. The modification allowed overcoming the known MTZ solubility problem leading us to obtain a bioconjugate more suitable for parental administration. The conjugates of various molecular weight polymers have been tested in vitro toward chemical degradation and digestive enzymes. It was found that molecular weight and shape of PEG is critical for the prodrugs stability. Good resistance in the stomach acidic media was found and a slow release of the drug in the large intestinal fluid may take place. In vivo studies carried out following i.v. or s.c. administration to mice revealed improved pharmacokinetics properties upon conjugation.</span></p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 9","pages":"Pages 783-788"},"PeriodicalIF":0.0,"publicationDate":"2005-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.04.015","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25208292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 18
A facile synthesis of new 2-carboxamido-3-carboxythiophene and 4,5,6,7-tetrahydro-2-carboxamido-3-carboxythieno[2,3-c]pyridine derivatives as potential endothelin receptors ligands 作为潜在内皮素受体配体的2-羧基氨基-3-羧基噻吩和4,5,6,7-四氢-2-羧基氨基-3-羧基噻吩[2,3-c]吡啶衍生物的简易合成
Pub Date : 2005-09-01 DOI: 10.1016/j.farmac.2005.06.005
Valeria Pittalà , Maria Modica , Giuseppe Romeo , Luisa Materia , Loredana Salerno , Mariangela Siracusa , Alfredo Cagnotto , Ilario Mereghetti , Filippo Russo

Endothelins (ETs) are the most ubiquitous, highly potent and unusually long-lasting peptidic constrictors of human vessels known. Elevated levels of the plasma concentration of ETs were observed in several diseases such as hypertension, acute myocardial infarction, congestive heart failure, renal failure, pulmonary hypertension, and atherosclerosis. ETs exert their activities via specific seven-transmembrane, G protein-coupled receptors. To date two receptor subtypes, endothelin A (ETA) and endothelin B (ETB), have been identified and cloned. A literature survey revealed that a number of compounds that bind ET receptors with affinity and selectivity are known, nevertheless these compounds belong only to few chemical classes. The aim of this work is the identification of an “hit compound” with novel chemical structure endowed with reasonable ET affinity and selectivity. Accordingly, new variously substituted 2-carboxamido-3-carboxythiophene derivatives (29–52) were synthesized. These compounds were tested for their ability to inhibit ETs binding in radioligand binding assay using CHO cells stably expressing human ETA and ETB receptors.

内皮素(ETs)是目前已知的最普遍、最有效、最持久的人类血管缩氨酸收缩剂。在高血压、急性心肌梗死、充血性心力衰竭、肾功能衰竭、肺动脉高压和动脉粥样硬化等多种疾病中均观察到血浆中ETs浓度升高。ETs通过特定的7跨膜G蛋白偶联受体发挥其活性。迄今为止,内皮素A (ETA)和内皮素B (ETB)两种受体亚型已被鉴定和克隆。文献调查显示,已知许多具有亲和力和选择性结合ET受体的化合物,但这些化合物仅属于少数化学类别。这项工作的目的是鉴定一种具有新的化学结构,具有合理的ET亲和力和选择性的“命中化合物”。据此,合成了新的不同取代的2-羧基氨基-3-羧基噻吩衍生物(29-52)。利用稳定表达人ETA和ETB受体的CHO细胞,在放射性配体结合试验中测试了这些化合物抑制ETs结合的能力。
{"title":"A facile synthesis of new 2-carboxamido-3-carboxythiophene and 4,5,6,7-tetrahydro-2-carboxamido-3-carboxythieno[2,3-c]pyridine derivatives as potential endothelin receptors ligands","authors":"Valeria Pittalà ,&nbsp;Maria Modica ,&nbsp;Giuseppe Romeo ,&nbsp;Luisa Materia ,&nbsp;Loredana Salerno ,&nbsp;Mariangela Siracusa ,&nbsp;Alfredo Cagnotto ,&nbsp;Ilario Mereghetti ,&nbsp;Filippo Russo","doi":"10.1016/j.farmac.2005.06.005","DOIUrl":"10.1016/j.farmac.2005.06.005","url":null,"abstract":"<div><p><span><span><span>Endothelins (ETs) are the most ubiquitous, highly potent and unusually long-lasting peptidic constrictors of human vessels known. Elevated levels of the plasma concentration of ETs were observed in several diseases such as hypertension, </span>acute myocardial infarction<span><span>, congestive heart failure, renal failure, </span>pulmonary hypertension, and </span></span>atherosclerosis<span>. ETs exert their activities via specific seven-transmembrane, G protein-coupled receptors. To date two receptor subtypes, endothelin A (ET</span></span><sub>A</sub>) and endothelin B (ET<sub>B</sub><span>), have been identified and cloned. A literature survey revealed that a number of compounds that bind ET receptors with affinity and selectivity are known, nevertheless these compounds belong only to few chemical classes. The aim of this work is the identification of an “hit compound” with novel chemical structure endowed with reasonable ET affinity and selectivity. Accordingly, new variously substituted 2-carboxamido-3-carboxythiophene derivatives (</span><em>29–52</em><span>) were synthesized. These compounds were tested for their ability to inhibit ETs binding in radioligand binding assay using CHO cells stably expressing human ET</span><sub>A</sub> and ET<sub>B</sub> receptors.</p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 9","pages":"Pages 711-720"},"PeriodicalIF":0.0,"publicationDate":"2005-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.06.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25208461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
CV2 - Editorial Board CV2 -编辑委员会
Pub Date : 2005-09-01 DOI: 10.1016/S0014-827X(05)00180-1
{"title":"CV2 - Editorial Board","authors":"","doi":"10.1016/S0014-827X(05)00180-1","DOIUrl":"https://doi.org/10.1016/S0014-827X(05)00180-1","url":null,"abstract":"","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 9","pages":"Page CO2"},"PeriodicalIF":0.0,"publicationDate":"2005-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0014-827X(05)00180-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"137290597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validated HPLC method for determination of amlodipine in human plasma and its application to pharmacokinetic studies 高效液相色谱法测定人血浆中氨氯地平及其在药动学研究中的应用
Pub Date : 2005-09-01 DOI: 10.1016/j.farmac.2005.06.012
A. Zarghi , S.M. Foroutan , A. Shafaati , A. Khoddam

A rapid, simple and sensitive high-performance liquid chromatography (HPLC) method has been developed for quantification of amlodipine in plasma. The assay enables the measurement of amlodipine for therapeutic drug monitoring with a minimum detectable limit of 0.2 ng ml−1. The method involves simple, one-step extraction procedure and analytical recovery was about 97%. The separation was performed on an analytical 125 × 4.6 mm i.d. Nucleosil C8 column. The wavelength was set at 239 nm. The mobile phase was a mixture of 0.01 M sodium dihydrogen phosphate buffer and acetonitrile (63:37, v/v) adjusted to pH 3.5 at a flow rate of 1.5 ml min–1. The calibration curve was linear over the concentration range 0.5–16 ng ml−1. The coefficients of variation for inter-day and intra-day assay were found to be less than 10%.

建立了一种快速、简便、灵敏的高效液相色谱法测定血浆中氨氯地平的含量。该检测方法能够测量用于治疗药物监测的氨氯地平,最低检测限为0.2 ng ml−1。方法简单,一步提取,分析回收率约为97%。采用125 × 4.6 mm id的核sil C8色谱柱进行分离。波长为239 nm。流动相为0.01 M磷酸二氢钠缓冲液与调节pH为3.5的乙腈(63:37,v/v)的混合物,流速为1.5 ml min-1。在0.5 ~ 16 ng ml−1的浓度范围内,校准曲线呈线性。日间和日间测定的变异系数均小于10%。
{"title":"Validated HPLC method for determination of amlodipine in human plasma and its application to pharmacokinetic studies","authors":"A. Zarghi ,&nbsp;S.M. Foroutan ,&nbsp;A. Shafaati ,&nbsp;A. Khoddam","doi":"10.1016/j.farmac.2005.06.012","DOIUrl":"10.1016/j.farmac.2005.06.012","url":null,"abstract":"<div><p><span><span>A rapid, simple and sensitive high-performance liquid chromatography (HPLC) method has been developed for quantification of amlodipine in plasma. The assay enables the measurement of amlodipine for </span>therapeutic drug monitoring with a minimum detectable limit of 0.2 ng ml</span><sup>−1</sup>. The method involves simple, one-step extraction procedure and analytical recovery was about 97%. The separation was performed on an analytical 125<!--> <!-->×<!--> <!-->4.6 mm i.d. Nucleosil C<sub>8</sub><span> column. The wavelength was set at 239 nm. The mobile phase was a mixture of 0.01 M sodium dihydrogen phosphate buffer and acetonitrile (63:37, v/v) adjusted to pH 3.5 at a flow rate of 1.5 ml min</span><sup>–1</sup>. The calibration curve was linear over the concentration range 0.5–16 ng ml<sup>−1</sup>. The coefficients of variation for inter-day and intra-day assay were found to be less than 10%.</p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 9","pages":"Pages 789-792"},"PeriodicalIF":0.0,"publicationDate":"2005-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.06.012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24916920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 122
2,1,3-Benzothiadiazine derivatives: synthesis and screening versus PDE4 enzyme 2,1,3-苯并噻二嗪衍生物的合成与PDE4酶的筛选
Pub Date : 2005-08-01 DOI: 10.1016/j.farmac.2005.05.009
Annalisa Tait, Amedeo Luppi, Rossella Avallone, Mario Baraldi

A series of N-1,3 disubstituted 2,1,3-benzothiadiazine derivatives (BTDs) were synthesized and evaluated for their inhibitory activity versus enzymatic isoform PDE4 extracted from U937 cell line. Some of the tested compounds showed a high PDE4 inhibitory activity at 100 μM and the IC50 value of the most interesting terms were evaluated. The structure–activity relationships of these compounds showed that the 3,5-di-tert-butyl-4-hydroxybenzyl moiety at N-1 position is important to obtain activity at micromolar level as previously reported. For the same compounds the antioxidant activity were evaluated highlighting 14 as the most significative one. The introduction of other bulky substituents in N-1 position is detrimental.

合成了一系列n -1,3二取代2,1,3-苯并噻唑二嗪衍生物(btd),并测定了其对U937细胞株酶促异构体PDE4的抑制活性。部分化合物在100 μM下表现出较高的PDE4抑制活性,并对最感兴趣项的IC50值进行了评价。这些化合物的构效关系表明,在N-1位置的3,5-二叔丁基-4-羟基苯基片段对获得微摩尔水平的活性很重要。对相同化合物的抗氧化活性进行了评价,其中14的抗氧化活性最强。在N-1位置引入其他大体积取代基是有害的。
{"title":"2,1,3-Benzothiadiazine derivatives: synthesis and screening versus PDE4 enzyme","authors":"Annalisa Tait,&nbsp;Amedeo Luppi,&nbsp;Rossella Avallone,&nbsp;Mario Baraldi","doi":"10.1016/j.farmac.2005.05.009","DOIUrl":"10.1016/j.farmac.2005.05.009","url":null,"abstract":"<div><p>A series of N-1,3 disubstituted 2,1,3-benzothiadiazine derivatives (BTDs) were synthesized and evaluated for their inhibitory activity versus enzymatic isoform PDE4 extracted from U937 cell line. Some of the tested compounds showed a high PDE4 inhibitory activity at 100 μM and the IC<sub>50</sub> value of the most interesting terms were evaluated. The structure–activity relationships of these compounds showed that the 3,5-di-<em>tert-</em><span>butyl-4-hydroxybenzyl moiety at N-1 position is important to obtain activity at micromolar level as previously reported. For the same compounds the antioxidant activity were evaluated highlighting </span><strong>14</strong> as the most significative one. The introduction of other bulky substituents in N-1 position is detrimental.</p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 8","pages":"Pages 653-663"},"PeriodicalIF":0.0,"publicationDate":"2005-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.05.009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24852298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Synthetic studies on heterocyclic natural products 杂环天然产物的合成研究
Pub Date : 2005-08-01 DOI: 10.1016/j.farmac.2005.01.007
Marco A. Ciufolini

This article reviews past and ongoing research in the author's laboratory directed toward the synthesis of natural products displaying an azaspirocyclic framework, or incorporating a medium-ring nitrogen heterocycle. New synthetic technologies were devised in order to address the synthetic problems posed by the target molecules. Thus, efforts in the area of azaspirocyclic substances have relied on an oxidative amidation of phenols promoted by iodobenzene diacetate, whereas access to medium-ring nitrogen heterocycles has been secured by means of a ring expansion sequence that relies on the fragmentation of an aziridine triggered by a homo-Brook transposition. Details of the development of these technologies are presented, together with applications to the total synthesis of FR-901483, TAN-1251C, cylindricines, and mitomycinoids.

这篇文章回顾了过去和正在进行的研究,在作者的实验室直接合成天然产物显示一个氮杂环框架,或纳入中环氮杂环。为了解决目标分子的合成问题,新的合成技术被设计出来。因此,氮杂环物质领域的研究依赖于二醋酸碘苯促进的酚的氧化酰胺化,而获得中环氮杂环的途径是通过环扩张序列获得的,该序列依赖于同源布鲁克转位引发的氮杂环断裂。详细介绍了这些技术的发展,以及在FR-901483、TAN-1251C、圆柱菌素和丝裂霉素类的全合成中的应用。
{"title":"Synthetic studies on heterocyclic natural products","authors":"Marco A. Ciufolini","doi":"10.1016/j.farmac.2005.01.007","DOIUrl":"10.1016/j.farmac.2005.01.007","url":null,"abstract":"<div><p><span>This article reviews past and ongoing research in the author's laboratory directed toward the synthesis of natural products displaying an azaspirocyclic framework, or incorporating a medium-ring nitrogen heterocycle. New synthetic technologies were devised in order to address the synthetic problems posed by the target molecules. Thus, efforts in the area of azaspirocyclic substances have relied on an oxidative amidation of phenols promoted by iodobenzene </span>diacetate<span>, whereas access to medium-ring nitrogen heterocycles has been secured by means of a ring expansion sequence that relies on the fragmentation of an aziridine triggered by a homo-Brook transposition. Details of the development of these technologies are presented, together with applications to the total synthesis of FR-901483, TAN-1251C, cylindricines, and mitomycinoids.</span></p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 8","pages":"Pages 627-641"},"PeriodicalIF":0.0,"publicationDate":"2005-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.01.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25243330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 27
Determination of hydrochlorothiazide and irbesartan in pharmaceuticals by fourth-order UV derivative spectrophotometry 四阶紫外导数分光光度法测定药品中的氢氯噻嗪和厄贝沙坦
Pub Date : 2005-08-01 DOI: 10.1016/j.farmac.2005.04.013
C. Vetuschi , A. Giannandrea , G. Carlucci , P. Mazzeo

The fourth-order derivative spectrum from the alcoholic sample is used. HCT can be determined by a specific peak–trough, of low intensity, at 330–340 nm. For IST evaluation, a peak–trough around 250–310 nm is available, common to both products, whose amplitude increases linearly only for low concentration values, while it decreases at higher values. The most difficult aspect of the analysis lies in how to find the optimal concentration range, so that both signals can be evaluated simultaneously. The best results were achieved by using a linear regression for HCT and a regression plane for IST.

采用酒精样品的四阶导数谱。HCT可以通过特定的低强度峰谷测定,波长为330-340 nm。对于IST评价,两种产品都有250-310 nm左右的峰谷,其振幅仅在低浓度值时线性增加,而在高浓度值时下降。分析中最困难的地方在于如何找到最优的浓度范围,使两个信号同时被评估。HCT采用线性回归,IST采用回归平面,效果最好。
{"title":"Determination of hydrochlorothiazide and irbesartan in pharmaceuticals by fourth-order UV derivative spectrophotometry","authors":"C. Vetuschi ,&nbsp;A. Giannandrea ,&nbsp;G. Carlucci ,&nbsp;P. Mazzeo","doi":"10.1016/j.farmac.2005.04.013","DOIUrl":"10.1016/j.farmac.2005.04.013","url":null,"abstract":"<div><p><span>The fourth-order derivative spectrum from the alcoholic sample is used. HCT can be determined by a specific peak–trough, of low intensity, at 330–340 nm. For </span>IST evaluation, a peak–trough around 250–310 nm is available, common to both products, whose amplitude increases linearly only for low concentration values, while it decreases at higher values. The most difficult aspect of the analysis lies in how to find the optimal concentration range, so that both signals can be evaluated simultaneously. The best results were achieved by using a linear regression for HCT and a regression plane for IST.</p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 8","pages":"Pages 665-670"},"PeriodicalIF":0.0,"publicationDate":"2005-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.04.013","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24852297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 42
CV2 - Editorial Board CV2 -编辑委员会
Pub Date : 2005-08-01 DOI: 10.1016/S0014-827X(05)00161-8
{"title":"CV2 - Editorial Board","authors":"","doi":"10.1016/S0014-827X(05)00161-8","DOIUrl":"https://doi.org/10.1016/S0014-827X(05)00161-8","url":null,"abstract":"","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 8","pages":"Page CO2"},"PeriodicalIF":0.0,"publicationDate":"2005-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0014-827X(05)00161-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136541865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study of electrochemical oxidation and determination of albendazole using a glassy carbon-rotating disk electrode 玻碳旋转圆盘电极电化学氧化测定阿苯达唑的研究
Pub Date : 2005-08-01 DOI: 10.1016/j.farmac.2005.05.004
André L. Santos, Regina M. Takeuchi, Marcela P. Mariotti, Marcelo F. De Oliveira, Maria V.B. Zanoni, Nelson R. Stradiotto

In this work, electrochemical oxidation of albendazole (ABZ) was carried out using a glassy carbon-rotating disk electrode. Development of electroanalytical methodology for ABZ quantification in pharmaceutical formulations was also proposed by using linear sweep voltammetric technique. Electrochemical oxidation is observed for ABZ at E1/2 = 0.99 V vs. Ag/AgClsat, when an anodic wave is observed. Kinetic parameters obtained for ABZ oxidation exhibited a standard heterogeneous rate constant for the electrodic process equal to (1.51 ± 0.07) × 10–5 cm s–1, with a αna value equal to 0.76. Limiting current dependence against ABZ concentration exhibited linearity on 5.0 × 10–5 to 1.0 × 10–2 mol l–1 range, being obtained a detection limit of 2.4 × 10–5 mol l–1. Proposed methodology was applied to ABZ quantification in pharmaceutical formulations.

本文采用玻碳旋转圆盘电极对阿苯达唑(ABZ)进行了电化学氧化。本文还提出了利用线性扫描伏安法定量药物制剂中ABZ的电分析方法。在E1/2 = 0.99 V条件下,ABZ与Ag/AgClsat发生了电化学氧化。得到的动力学参数表明,ABZ氧化过程的标准非均相速率常数为(1.51±0.07)× 10-5 cm s-1, αna值为0.76。ABZ浓度与限流关系在5.0 × 10-5 ~ 1.0 × 10-2 mol - 1范围内呈线性关系,检出限为2.4 × 10-5 mol - 1。该方法已应用于制剂中ABZ的定量分析。
{"title":"Study of electrochemical oxidation and determination of albendazole using a glassy carbon-rotating disk electrode","authors":"André L. Santos,&nbsp;Regina M. Takeuchi,&nbsp;Marcela P. Mariotti,&nbsp;Marcelo F. De Oliveira,&nbsp;Maria V.B. Zanoni,&nbsp;Nelson R. Stradiotto","doi":"10.1016/j.farmac.2005.05.004","DOIUrl":"10.1016/j.farmac.2005.05.004","url":null,"abstract":"<div><p><span>In this work, electrochemical oxidation of albendazole (ABZ) was carried out using a glassy carbon-rotating disk electrode. Development of electroanalytical methodology for ABZ quantification in pharmaceutical formulations was also proposed by using linear sweep voltammetric technique. Electrochemical oxidation is observed for ABZ at </span><em>E</em><sub>1/2</sub> <!-->=<!--> <!-->0.99 V vs. Ag/AgCl<sub>sat</sub>, when an anodic wave is observed. Kinetic parameters obtained for ABZ oxidation exhibited a standard heterogeneous rate constant for the electrodic process equal to (1.51<!--> <!-->±<!--> <!-->0.07)<!--> <!-->×<!--> <!-->10<sup>–5</sup> cm s<sup>–1</sup>, with a <em>αn</em><sub>a</sub> value equal to 0.76. Limiting current dependence against ABZ concentration exhibited linearity on 5.0<!--> <!-->×<!--> <!-->10<sup>–5</sup> to 1.0<!--> <!-->×<!--> <!-->10<sup>–2</sup> mol l<sup>–1</sup> range, being obtained a detection limit of 2.4<!--> <!-->×<!--> <!-->10<sup>–5</sup> mol l<sup>–1</sup>. Proposed methodology was applied to ABZ quantification in pharmaceutical formulations.</p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 8","pages":"Pages 671-674"},"PeriodicalIF":0.0,"publicationDate":"2005-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.05.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25140500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 18
期刊
Farmaco (Societa chimica italiana : 1989)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1